Expanded Indication for Gilead Biktarvy for HIV with suppressed viral loads, pre-existing resistance gets USFDA okay Ruchika Sharma27 Feb 2024 12:30 PM ISTFoster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved a new, expanded indication for Biktarvy...
AstraZeneca blood disorder drug recommended for EU nod Ruchika Sharma27 Feb 2024 11:29 AM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) as an...
Piramal Pharma gets 2 USFDA observations for Lexington facility Ruchika Sharma26 Feb 2024 4:03 PM ISTMumbai: Piramal Pharma has announced that the US Food and Drug Administration (US FDA) has concluded a Pre-Approval Inspection (PAI)...
MP: Raid at Ayurvedic medicine shop, body parts of wild animals seized Ruchika Sharma26 Feb 2024 3:08 PM ISTVidisha: Forest officials raided an Ayurvedic medicine shop and seized body parts of wild animals used in witchcraft and "power-enhancing"...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Shilpa Medicare secures Europe approval for smoking cessation drug Varenicline Ruchika Sharma26 Feb 2024 12:42 PM ISTVarenicline is indicated for smoking cessation in adults. It is used for quitting smoking.
Zydus Lifesciences bags WHO prequalification nod for Miltefosine formulation, API to treat Leishmaniasis Ruchika Sharma26 Feb 2024 12:21 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received the World Health Organisation (WHO) prequalification approval ...
CDSCO Panel Approves Roche's protocol amendment proposal for anti-cancer drug Atezoluzumab study Dr. Divya Colin25 Feb 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Bristol Myers Squibb gets EMA Committee positive opinion for Reblozyl for adults with Transfusion-Dependent Anemia due to Low-to Intermediate-Risk Myelodysplastic Syndromes Ruchika Sharma25 Feb 2024 3:30 PM ISTPrinceton: Bristol Myers Squibb has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Bristol Myers Squibb, Immunocore Holdings ink pact to evaluate IMC-F106C, nivolumab combo in registrational Phase 3 first-line advanced cutaneous melanoma trial Ruchika Sharma25 Feb 2024 2:00 PM ISTOxfordshire: Immunocore Holdings plc, a commercial-stage biotechnology company has announced that it has entered into a clinical trial...
AbbVie, Tentarix collaborate to develop conditionally-active, multi-specific biologics for oncology, immunology Ruchika Sharma25 Feb 2024 12:45 PM ISTNorth Chicago: AbbVie Inc. and Tentarix Biotherapeutics have announced a multi-year collaboration focused on the discovery and development of...
EU medicines regulator backs Biogen ALS drug Ruchika Sharma25 Feb 2024 11:30 AM ISTCambridge: Biogen Inc. has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...
